Michael Buys, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8868 Saddleback Rd, Park City, UT 84098 Phone: 801-205-1040 |
Dr. Nathaniel David Kofford, M.D., MSPH Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley Drive, Park City, UT 84060 Phone: 435-658-7000 Fax: 801-990-1912 |
Lee Gerstein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1439 Willow Loop, Park City, UT 84098 Phone: 425-785-4141 |
Dr. Watson Allen Bowes Iii, M.D. Anesthesiology - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 7905 Long Rifle Rd, Park City, UT 84098 Phone: 801-442-5692 |
Courtney Mitchell Bailey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley, Park City Medical Center, Park City, UT 84060 Phone: 435-658-7000 Fax: 801-733-5618 |
Dr. Andrew P. Talbott, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1122 Center Dr Ste D350, Park City, UT 84098 Phone: 435-714-7277 Fax: 435-214-2254 |
Dr. Joseph Morelli, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley, Park City Medical Center, Park City, UT 84060 Phone: 435-658-7000 |
Scott Frederic Olsen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3349 Niblick Dr, Park City, UT 84098 Phone: 702-521-6768 |
Robert Franklin Finnegan, MD Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Pinebrook Blvd, #i-5, Park City, UT 84098 Phone: 801-391-2063 Fax: 435-604-0326 |
News Archive
In a new study in patients with osteoarthritis (OA) of the knee, at 12 months, total femorotibial cartilage thickness loss was reduced in sprifermin (recombinant human fibroblast growth factor 18)-treated knees compared to placebo-treated knees, with effects being significant in the lateral femorotibial compartment but not in the central femorotibial compartment.
A new study out of Ohio State University thats used intoxicated honey bees could provide greater insights into the effects of alcohol on a person's behaviour.
The following quote is attributed to Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA's Center for Drug Evaluation and Research.
Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, and Trimeris, Inc., announced today that they have entered into a definitive agreement under which Synageva will merge with Trimeris in an all-stock transaction.
› Verified 1 days ago